A detailed history of Hantz Financial Services, Inc. transactions in Omnicell, Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 5 shares of OMCL stock, worth $151. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$151
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

BUY
$24.63 - $35.46 $123 - $177
5 New
5 $0
Q4 2021

Aug 06, 2024

BUY
$153.26 - $183.62 $132,723 - $159,014
866 Added 22.19%
4,768 $860,000
Q3 2021

Aug 06, 2024

BUY
$141.84 - $160.88 $251,482 - $285,240
1,773 Added 83.28%
3,902 $579,000
Q2 2021

Aug 06, 2024

BUY
$129.91 - $151.45 $125,363 - $146,149
965 Added 82.9%
2,129 $322,000
Q1 2021

Aug 06, 2024

BUY
$117.78 - $143.9 $137,095 - $167,499
1,164 New
1,164 $151,000

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $1.34B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.